Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

National Health Research Institutes patents

Recent patent applications related to National Health Research Institutes. National Health Research Institutes is listed as an Agent/Assignee. Note: National Health Research Institutes may have other listings under different names/spellings. We're not affiliated with National Health Research Institutes, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | National Health Research Institutes-related inventors

Method for genotyping mycobacterium tuberculosis

The present application provides a method for genotyping m. Tuberculosis, comprising obtaining amplifying and obtaining a first dna fragment from a dna sample by using one or more primer sets selected from the group consisting of primer sets 1 to 25 (seq id nos. ... National Health Research Institutes

Heterocyclic compounds and use thereof

Heterocyclic compounds of formula (i) shown herein. Also disclosed is a pharmaceutical composition containing one of the heterocyclic compounds. ... National Health Research Institutes

Method of stimulating tlr9-activated immune response

A method of stimulating a tlr9-activated immune response or enhancing a tlr9-activated immune response to an antigen is disclosed herein. Tlr9 is the cellular receptor for cpg-odn, and current developed cpg-odn has low activity to rabbit tlr9. ... National Health Research Institutes

Method of producing exosomes from stem cells and use thereof

. . A method of producing induced exosomes, the method comprising: contacting an isolated population of stem cells with an amount of a prostaglandin e receptor 4 (ep4) antagonist effective for inducing release of exosomes, whereby induced exosomes are released from the stem cells, and isolating the induced exosomes.. . ... National Health Research Institutes

Heterocyclic compounds and use thereof

Heterocyclic compounds of formula (i) shown herein. Also disclosed are pharmaceutical compositions containing the heterocyclic compounds and methods of using the heterocyclic compounds to mobilize hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation. ... National Health Research Institutes

Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agents

A composition in a water-in-oil-in-water (w/o/w) emulsion is disclosed. The composition comprises: (a) a continuous aqueous phase, comprising h2o; (b) an oil phase or an oil shell, dispersed in the continuous aqueous phase; and (c) a hydrophilic polymer, stabilizing an interface between the continuous aqueous phase and the oil phase or the oil shell to form the water-in-oil-in-water (w/o/w) emulsion. ... National Health Research Institutes

Lipidated streptococcus pneumoniae antigen compositions, methods of preparation and use

There are provided compositions and methods for prevention or treatment of streptococcus pneumoniae (sp)-associated diseases. More specifically, there are provided recombinant lipidated fusion proteins comprising pneumococcal surface antigen a (psaa), the recombinant lipidated fusion proteins comprising, from n-terminus to c-terminus, the n-terminal native lipid signal peptide of psaa and the c-terminal structural gene for psaa. ... National Health Research Institutes

Use of 5-methoxytryptophan as diagnostic agent of inflammatory diseases

A diagnostic method for inflammatory diseases, and the diagnostic kit used in the method. The diagnostic method includes the use of a novel tryptophan metabolite, 5-methoxytryptophan (5-mtp), as a diagnostic biomarker of inflammation. ... National Health Research Institutes

Method for determining deletions in hbv pre-s2 region

A method of detecting pre-s2 deletion mutant lhbs is disclosed herein. The method comprises incubating a biological sample with a first antibody to captured hbs proteins; detecting the lhbs and wt lhbs bound to the immobilized first antibody, respectively; and calculating the amount of the pre-s2 deletion mutant lhbs protein by subtracting the amount of the wt lhbs protein from that of the lhbs protein. ... National Health Research Institutes

Endotoxin nanovesicles: hydrophilic gold nanodots control lipopolysaccharide assembly for modulating immunological responses

An endotoxin nanovesicle for enhancing type 1 t helper cell-induced immunological responses is disclosed. The endotoxin nanovesicle comprises: (a) lipopolysaccharide molecules, assembled into a vesicle with a wall surrounding an inner space; and (b) hydrophilic gold nanodots, localized in the wall of the vesicle. ... National Health Research Institutes

Thiazolidinone compounds and use thereof

A pharmaceutical composition containing a compound of formula (i) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. ... National Health Research Institutes

Progenitor cells, method for preparation thereof and uses thereof

The present application provides progenitor cells and a preparing method thereof. The preparing method comprises obtaining a tissue sample containing myometrium from uterus, treating the tissue sample with collagenase, and culturing the treated tissue sample to obtain the progenitor cells, wherein the progenitor cell is multipotent and immunomodulatory. ... National Health Research Institutes

Methods to upregulate and suppress an expression of immunomodulatory cells

The present application provides a method of upregulating an expression of immumodulatory cells in vitro comprising treating the immumodulatory cells with il-25 to increase an expression of pd-l1. The present application also provides a method for treatment of immune disorders by the aforementioned methods. ... National Health Research Institutes

Aminothiazole compounds

Aminothiazole compounds of formula (i) shown herein and pharmaceutical compositions containing one of such compounds.. . ... National Health Research Institutes

08/10/17 / #20170224776

Methods to enhance nerve regeneration utilizing neural stem cells and il12p40

The present application provides a composition and methods to enhance nerve regeneration utilizing at least one component of neural stem cells or il12p40. The composition comprises neural stem cells and a neurotrophic factor, which is constructed by il12p40 as at least one subunit. ... National Health Research Institutes

03/02/17 / #20170057956

Histone deacetylase inhibitors

Fused bicycle indol, indoline, azoindole, or azoindoline compounds of formula (i) set forth herein. Also disclosed are pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing the same. ... National Health Research Institutes

02/09/17 / #20170037448

Use of known compounds as d-amino acid oxidase inhibitors

The invention utilizes virtual screening strategy to seek for current market drugs as anti-schizophrenia therapy drug repurposing. Drug repurposing strategy finds new uses other than the original medical indications of existing drugs. ... National Health Research Institutes

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with National Health Research Institutes in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for National Health Research Institutes with additional patents listed. Browse our Agent directory for other possible listings. Page by